MIR3613 and breast carcinoma: Nearly 46% of TCGA breast cancer tumor samples were subjected to either heterozygous or homozygous deletions at MIR3613 locus and approximately 42% of breast cancer cell lines from Cancer Cell Line Encyclopedia (CCLE) showed copy number deletions of MIR3613 (Fig. 1a).